Á lódáil...
Batch-to-Batch Consistency of SB4 and SB2, Etanercept and Infliximab Biosimilars
BACKGROUND: Biosimilars must meet stringent regulatory requirements, both at the time of authorization and during their lifecycle. Yet it has been suggested that divergence in quality attributes over time may lead to clinically meaningful differences between two versions of a biologic. Therefore, th...
Na minha lista:
| Foilsithe in: | BioDrugs |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Springer International Publishing
2020
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7113226/ https://ncbi.nlm.nih.gov/pubmed/31925703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-019-00402-0 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|